Goldenwell Biotech (GWLL) Asset Utilization Ratio (2021 - 2025)

Goldenwell Biotech has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.0 in Q3 2025.

• For the quarter ending Q3 2025, Asset Utilization Ratio fell 131.89% year-over-year to 0.0; the trailing twelve-month figure through Sep 2025 stood at 0.0 (down 131.89% YoY), and the FY2024 full-year result was 0.0, down 92.02% from the prior year.
• Asset Utilization Ratio for Q3 2025 stood at 0.0, up from 0.0 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.22 in Q2 2023, with the low at 0.0 in Q2 2025.
• Historically, Asset Utilization Ratio has averaged 0.06 across 5 years, with a median of 0.01 in 2023.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 3001.95% — and 2025, when it plunged 131.89%.
• Goldenwell Biotech's Asset Utilization Ratio stood at 0.04 in 2021, then surged by 383.91% to 0.19 in 2022, then slumped by 93.93% to 0.01 in 2023, then tumbled by 100.83% to 0.0 in 2024, then sank by 611.56% to 0.0 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q3 2025), 0.0 (Q2 2025), and 0.0 (Q1 2025), per Business Quant data.